Episodes (Page 25)
✨
AI discussions at HLTH Europe and VR for health.
✨
J&J's Spravato on track for blockbuster status.
✨
AI helps device manufacturers navigate global regulations.
DJ Fang
✨
US approves more new drugs than EU, especially cell/gene and cancer therapies.
✨
Key considerations for genetic analysis in advanced therapies.
Chandler Walker
Janelle Hart
✨
Top 10 drugs of Q1 and Pfizer's R&D leadership changes.
✨
Korean AI drug development lags behind global leaders.
✨
Producers must collect packaging data for EPR laws.
Michael Washburn
✨
Improving communication between biotech and biopharma sectors.
✨
FDA encourages more frequent meetings with cell/gene therapy sponsors.
✨
Lilly's Alzheimer's drug approved; challenges of late-stage ADCs.
Ian Thompson
✨
Midyear review of biopharma dealmaking in 2024.
Joseph Haas
Kevin Grogan
Mandy Jackson
✨
Owlstone Medical develops breath biopsy products for early detection.
✨
In Vivo Podcast episode featuring Stefan Woxström.
Stefan Woxstrom
✨
Global CEO remuneration trends and Merck KgaA's late-stage loss.
✨
Bayer Consumer Health celebrates Aspirin's 125th anniversary.
Rachel Koontz
Reese Fitzpatrick
✨
FDA's diversity action plan guidance and AI guidance discussed.
✨
New overseas data transfer rules for Chinese biotechs.
Angus Shipo Xie
✨
Outlook for 2025 pharmaceutical launches.
✨
LungLife AI CEO discusses regulatory and reimbursement journey.
Paul Pagano